Randomized clinical trial on the need for antibiotic to treat low-risk catheter bacteremia due to coagulase-negative staphylococci.

Fundació Parc Taulí0 个研究点目标入组 250 人开始时间: 2018年4月9日最近更新: 2022年5月2日

适应症

试验速览

暂无简介。

•1. Men and women over 18 years of age
•2. Bacteremia due to coagulase-negative staphylococcal related to the venous catheter defined as detection of growth of coagulase-negative staphylococci (excluding S lugdunensis) in patients with a venous catheter, with the presence of clinical symptoms of infection and in the absence of other apparent foci of bacteremia, with the exception of the catheter itself.
•3. Patients without risk factors for complications defined as absence of: septic shock, neutropenia (<500 Ne/uL), coagulase-negative staphylococci of the S lugdunensis type, moderate-severe valvular heart disease, artificial endovascular devices other than the catheter and signs of septic thrombophlebitis
•4. Patients who have had the catheter removed within 24h prior to inclusion
•5. Patients who have signed informed consent to participate in the study
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 125
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 125

•1. Pregnant and breast-feeding patients
•2. Patients who have not had the catheter removed
•3. Patients with compromise of immunity
•4. Hemodynamically unstable patients
•5. Patients with prosthetic materials other than the catheter
•6. Patients unable to give their informed consent freely or with inadequate cognitive capacity
•7. Any circumstance that, at the discretion of the physician, may involve a risk or clinical detriment to the participation of the patient in the study or that interferes with the assessments of the same.

发起方

Fundació Parc Taulí